End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.04 CNY | +6.17% | +14.89% | -23.60% |
Apr. 29 | PhiChem Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 28 | PhiChem Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company returns high margins, thereby supporting business profitability.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.60% | 820M | - | ||
+11.76% | 63.22B | A- | ||
-3.51% | 46.34B | A- | ||
+13.09% | 39.97B | B+ | ||
+19.67% | 25.46B | A- | ||
+8.37% | 18.68B | C+ | ||
+1.44% | 17.24B | B+ | ||
-20.33% | 15.81B | A- | ||
+0.36% | 14.9B | B+ | ||
-12.98% | 13.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300398 Stock
- Ratings PhiChem Corporation